Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung

Cancer Genetics and Cytogenetics

Volumn 117, Issue 1, 2000, Pages 9-18

  Sugita, Michio ^a,c   Tanaka, Naotake ^a,c   Davidson, Susan ^b   Sekiya, Souei ^c   Varella Garcia, Marileila ^a   West, James ^a   Drabkin, Harry A ^a   Gemmill, Robert M ^d  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ARTICLE; CELL LINE; CHROMOSOME 3Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; LUNG TUMOR; OVARY CARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; UTERINE CERVIX TUMOR;

BLOTTING, SOUTHERN; CHROMOSOMES, ARTIFICIAL, YEAST; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0033982439     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(99)00135-1     Document Type: Article

References (29)

1. Biedler J.L. Genetic aspects of multidrug resistance. Cancer. 70:1992;1799-1809.
2. Leach F.S., Elledge S.J., Sherr C.J., Willson J.K., Markowitz S., Kinzler K.W., Vogelstein B. Amplification of cyclin genes in colorectal carcinomas. Cancer Res. 53:1993;1986-1989.
3. Yin D.X., Schimke T.R. Inhibition of apoptosis by overexpressing Bcl-2 enhances gene amplification by a mechanism independent of aphidicolin pretreatment. Proc Natl Acad Sci USA. 93:1996;3394-3398.
4. Koskinen P.J., Alitalo K. Role of myc amplification and overexpression in cell growth, differentiation and death. Semin Cancer Biol. 4:1993;3-12.
5. Forozan F., Karhu R., Kononen J., Kallioniemi A., Kallioniemi O.P. Genome screening by comparative genomic hybridization. Trends Genet. 13:1997;405-409.
6. Heselmeyer K., Schrock E., du Manoir S., Blegen H., Shah K., Steinbeck R., Auer G., Reid T. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA. 93:1996;479-484.
7. Heselmeyer K., Macville M., Schrock E., Blegen H., Hellstrom A.C., Shah K., Auer G., Ried T. Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosom Cancer. 19:1997;233-240.
8. Iwabuchi H., Sakamoto M., Sakunaga H., Ma Y.Y., Carcangiu M.L., Pinkel D., Yang-Feng T.L., Gray J.W. Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res. 55:1995;6172-6180.
9. Arnold N., Hagele L., Walz L., Schempp W., Pfisterer J., Bauknecht T., Kiechle M. Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosom Cancer. 16:1996;46-54.
10. Sonoda G., Palazzo J., du Manoir S., Godwin A.K., Feder M., Yakushiji M., Testa J.R. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosom Cancer. 20:1997;320-328.
11. Ried T., Petersen I., Holtgreve-Grez H., Speicher M.R., Schrock E., du Manoir S., Cremer T. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res. 54:1994;1801-1806.
12. Brass N., Ukena I., Remberger K., Mack U., Sybrecht G.W., Meese E.U. DNA amplification on chromosome 3q26.1~q26.3 in squamous cell carcinoma of the lung detected by reverse chromosome painting. Eur J Cancer. 32A:1996;1205-1208.
13. Balsara B.R., Sonoda G., du Manoir S., Siegfried J.M., Gabrielson E., Testa J.R. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res. 57:1997;2116-2120.
14. Brzoska P.M., Levin N.A., Fu K.K., Kaplan M.J., Singer M.I., Gray J.W., Christman M.F. Frequent novel DNA copy number increase in squamous cell head and neck tumors. Cancer Res. 55:1995;3055-3059.
15. Speicher M.R., Howe C., Crotty P., du Manoir S., Costa J., Ward D.C. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res. 55:1995;1010-1013.
16. Bockmuhl U., Schwendel A., Dietel M., Petersen I. Distinct patterns of chromosomal alternations in high- and low-grade head and neck squamous cell carcinomas. Cancer Res. 56:1996;5325-5329.
17. Pere H., Tapper J., Wahlstrom T., Knuutila S., Butzow R. Distinct chromosomal imbalances in uterine serous and endometrioid carcinomas. Cancer Res. 58:1998;892-895.
18. Soder A.I., Hoare S.F., Muir S., Going J.J., Parkinson E.K., Keith W.N. Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene. 14:1997;1013-1021.
19. Mullokandov M.R., Kholodilov N.G., Atkin N.B., Burk R.D., Johnson A.B., Klinger H.P. Genomic alterations in cervical carcinoma. losses of chromosome heterozygosity and human papilloma virus tumor status Cancer Res. 56:1996;197-205.
20. Gemmill R.M., Chumakov I., Scott P., Waggoner B., Rigault P., Cypser J., Chen Q., Weissenbach J., Gardiner K., Wang H., Pekarski Y., Le Gall I., Le Paslier D., Guillon S., Li E., Robinson L., Hahner L., Todd S., Cohen D., Drabkin H.A. A second-generation YAC-contig map for human chromosome 3. Nature. 377S:1995;299-319.
21. Drabkin H.A., Wright M., Jonsen M., Varkony T., Jones C., Sage M., Gold S., Erickson P. Development of a somatic cell hybrid mapping panel and molecular probes for human chromosome 3. Genomics. 8:1990;435-446.
22. Feng J., Funk W.D., Wang S.-S., Weinrich S.L., Avilion A.A., Chiu C.-P., Adams R.R., Chang E., Allsopp R.C., Yu J., Le S., West M.D., Harley C.B., Andrews W.H., Greider C.W., Villeponteau B. The RNA component of human telomerase. Science. 269:1995;1236-1241.
23. Counter C.M., Gupta J., Harley C.B., Leber B., Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood. 85:1995;2315-2320.
24. Chadeneau C., Hay K., Hirte H.W., Gallinger S., Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res. 55:1995;2533-2536.
25. Blasco M.A., Rizen M., Greider C.W., Hanahan D. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet. 12:1996;200-204.
26. Meyerson M., Counter C.M., Eaton E.N., Ellisen L.W., Steiner P., Caddle S.D., Ziaugra L., Beijersbergen R.L., Davidoff M.J., Liu Q., Bacchetti S., Haber D.A., Weinberg R.A. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell. 90:1997;785-795.
27. Yashima K., Litzky L.A., Kaiser L., Rogers T., Lam S., Wistuba I.I., Milchgrub S., Srivastava S., Piatyszek M.A., Shay J.W., Gazdar A.F. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res. 57:1997;2373-2377.
28. Gyapay G., Morissette J., Vignal A., Dib C., Fizames C., Millasseau P., Marc S., Bernardi G., Lathrop M., Weissenbach J. The 1993-94 Genethon human genetic linkage map. Nat Genet. 7:1994;246-339.
29. Shaytesh L., Lu Y., Kuo W.-L., Baldocchi R., Godfrey T., Collins C., Pinkel D., Powell B., Mills G.B., Gray J.W. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet. 21:1999;99-102.